Search
ASCO 2025: PharmaMar presented data showing that the combo of Zepzelca and Tecentriq significantly improved survival as first-line maintenance therapy for extensive-stage small cell lung cancer
Global Product Lead José Antonio López-Vilariño describes the data and VP of Strategic Development Pascal Besman puts the result in...
Jun 3
Biotech industry veteran Pascal Besman shares advice for European companies on how to best present yourself to U.S. investors
He describes keys such as having a U.S. listing, keeping powerpoint presentations concise, and following the actions of a peer group.
Sep 17, 2024
Since 1986, Madrid's PharmaMar has been searching the world's oceans for new cancer medicines - it has already led to three approved drugs
Managing Director Luis Mora walks us through the company's development process, from divers in the ocean, to sample testing, and...
Sep 17, 2024
.png){kind=logo}
